Results 301 to 310 of about 596,432 (340)

Effect of Quantitative Structural Properties and Drug Formulation in Four Cannabinoids (Cannabidiol, Cannabigerol, Cannabichromene, and Cannabinol) on Their Lymphatic Transport after Enteral Administration in Rats. [PDF]

open access: yesMol Pharm
Ryšánek P   +15 more
europepmc   +1 more source

Exploring the potential of polymers: advancements in oral nanocarrier technology. [PDF]

open access: yesBeilstein J Nanotechnol
Silva RA   +4 more
europepmc   +1 more source

The Neuroprotective Role of Curcumin: From Molecular Pathways to Clinical Translation-A Narrative Review. [PDF]

open access: yesNutrients
Lehoczki A   +10 more
europepmc   +1 more source

Bioavailability of Digoxin

New England Journal of Medicine, 1971
A variable or poor response to a therapeutic agent may not have its origin in the patient; it may be due to a formulation defect in the drug product administered. The most commonly recognized formulation defect in a dosage form such as a tablet is a deficiency or excess of the active ingredient.
Trieste G. Vitti   +2 more
openaire   +3 more sources

Bioavailability of tolamolol

European Journal of Clinical Pharmacology, 1976
Bioavailability of capsule and tablet formulations of tolamolol were compared by measuring plasma concentration of tolamolol and reduction in maximum exercise heart rate over a period of twelve hours in eight healthy subjects in a two-way cross-over study.
D. A. Stopher   +4 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy